Gene · 6839
Papers3,037
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 3,037
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Differential tyrosine phosphorylation status of the nuclear scaffold Parafibromin/CDC73 determines its role in cancer development. | Biochem Biophys Res Commun | 2026 | 42772177 | PubTator, text mining | PubMed |
| Chaetocin Induces Ferroptosis in Cisplatin-Resistant Ovarian Cancer Cells Through Neddylation-Mediated TFRC Upregulation. | Phytother Res | 2026 | 42734152 | PubTator, text mining | PubMed |
| Nuclear amphiregulin and lamin A contribute to genomic stability and the response to replication stress via regulation of heterochromatin. | Oncogene | 2026 | 42581070 | PubTator, text mining | PubMed |
| Exploratory Transcriptomic Profiling of Vein Tissue from Diabetic Patients Undergoing Arteriovenous Fistula Creation for Hemodialysis. | J Atheroscler Thromb | 2026 | 42557021 | PubTator, text mining | PubMed |
| Single-cell and spatial transcriptomics reveal SUV39H1 as a master epigenetic driver of immunosuppressive niche and stemness in bladder cancer. | Transl Oncol | 2026 | 42492366 | PubTator, text mining | PubMed |
| CTCF primes repressive chromatin for rapid BRCA1/BARD1 recruitment to drive homologous recombination repair of DNA double-strand breaks. | Nucleic Acids Res | 2026 | 42475683 | PubTator, text mining | PubMed |
| Chromatin chronicles: Unlocking the therapeutic potential of histone modifiers in hepatocellular carcinoma. | Med Oncol | 2026 | 42360649 | PubTator, text mining | PubMed |
| Dual inhibition of PRMT1 and SUV39H1 suppresses breast cancer progression and enhances immunotherapy response. | Int J Biol Sci | 2026 | 42328454 | PubTator, text mining | PubMed |
| Identification of the cellular factor KLF16 as a novel epigenetic repressor of HIV-1 transcription. | Res Sq | 2026 | 42281995 | PubTator, text mining | PubMed |
| Epigenetic control of telomeric RNA maintains heterochromatin in telomerase-driven cancers. | Signal Transduct Target Ther | 2026 | 42236690 | PubTator, text mining | PubMed |
| LCP2 mediates SUV39H1-driven cellular senescence-related chemoresistance in natural killer/T-cell lymphoma. | Cell Death Dis | 2026 | 42209466 | PubTator, text mining | PubMed |
| Integrative transcriptomic and single-cell analysis reveals metabolic reprogramming and hexosamine biosynthesis-mediated tumor microenvironment remodeling in prostate cancer. | Discov Oncol | 2026 | 42183963 | PubTator, text mining | PubMed |
| ZNF184 negatively regulates HR repair and predicts poor prognosis in acute lymphoblastic leukemia. | Nucleic Acids Res | 2026 | 42165129 | PubTator, text mining | PubMed |
| Identification of the cellular transcription factor KLF16 as a novel repressive epigenetic repressor of HIV-1 transcription. | bioRxiv | 2026 | 42146495 | PubTator, text mining | PubMed |
| Inhibition of SUV39H1 as a potent therapeutic target in multiple myeloma. | Haematologica | 2026 | 41988779 | PubTator, text mining | PubMed |
| SUV family histone methyltransferases correlate with nuclear lamina remodeling and clinical outcome in cancer: integrative pan-cancer TCGA analysis and experimental evidence. | Sci Rep | 2026 | 41957462 | PubTator, text mining | PubMed |
| Repressive chromatin regulates fibrotic potential through Suv39h1 in the heart. | Cardiovasc Res | 2026 | 41913946 | PubTator, text mining | PubMed |
| Epigenetic Activity of Cancer Therapy Drugs Revealed by HeLa TI Cell-Based Assay. | Epigenomes | 2026 | 41892363 | PubTator, text mining | PubMed |
| Lamin A/C as a Molecular Link Between Nuclear Organization, Chromatin Dynamics, and Tumor Progression. | Cells | 2026 | 41892292 | PubTator, text mining | PubMed |
| Transcriptional competence defines the heterochromatin nucleating potential of isolated MSR units. | Nat Commun | 2026 | 41857002 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6839/papers